DocGo Inc (DCGO)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $20.55M
Last updated: Nov 17, 2026 at 11:02 AM ET
DocGo Inc (DCGO) Stock Forecast
Analysts expect DocGo (DCGO) to earn -$0.93 per share in the fiscal year ending Dec 31, 2026, on revenue of $299.39M. Of 5 analysts, 2 rate the stock Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 2.40, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 40% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 20.0% |
| Buy | 1 | 20.0% |
| Hold | 3 | 60.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 5
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus turns from a loss to a profit and revenue estimates rise 3.2%.
- Fiscal year ending Dec 31, 2026
- -$0.93
- EPS consensus, revenue $299.39M
- Fiscal year ending Dec 31, 2027
- $0.02
- EPS consensus, revenue $309.09M
- Next report
- Mar 15, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.93 | -$1.07 to -$0.80 | 2 | $299.39M | $297.08M to $300.60M | 5 |
| Dec 31, 2027 | $0.02 | -$0.18 to $0.22 | 2 | $309.09M | $289.00M to $322.68M | 5 |
Quarterly Estimates
The EPS consensus falls from -$0.07 for the quarter ending Dec 31, 2026 to -$0.29 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.07 | -$0.08 to -$0.06 | 7 | $79.17M | $73.18M to $84.31M | 7 |
| Mar 31, 2027 | -$0.29 | -$0.37 to -$0.22 | 2 | $77.80M | $73.91M to $80.64M | 3 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 1 upward and 2 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.43.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.93 | -$0.79 | -$0.79 | -$0.79 | -$0.43 | N/A |
| Fiscal year ending Dec 31, 2027 | $0.02 | $0.14 | $0.14 | $0.14 | $0.19 | -90.1% |
| Quarter ending Mar 31, 2027 | -$0.29 | -$0.31 | -$0.31 | -$0.31 | -$0.33 | N/A |
Frequently Asked Questions About DCGO
What is the DCGO stock forecast?
Consensus analyst estimates put DocGo's EPS at -$0.93 for the fiscal year ending Dec 31, 2026, on revenue of $299.39M. The consensus rating from 5 analysts is Buy.
How do analysts rate DCGO stock?
Of 5 analysts covering DocGo, 1 rates it Strong Buy, 1 Buy, 3 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from DCGO next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.93, with estimates from -$1.07 to -$0.80 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.02, with estimates from -$0.18 to $0.22 from 2 analysts.
What revenue do analysts expect from DocGo next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $299.39M, with estimates from $297.08M to $300.60M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $309.09M, with estimates from $289.00M to $322.68M.
How many analysts cover DCGO?
5 analysts rate DocGo stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
DCGO pages: Overview, Earnings, Forecast, Financials, Competitors